NextCure, Inc.
NXTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $13 | $13 | $22 |
| - Cash | $7 | $5 | $22 | $28 |
| + Debt | $4 | $5 | $6 | $6 |
| Enterprise Value | – | $13 | -$3 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$27 | -$11 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$27 | -$11 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.22 | -11.29 | -4.703 | -4.972 |
| % Growth | 71.5% | -140.1% | 5.4% | – |
| Operating Cash Flow | -$6 | -$23 | -$13 | -$7 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$23 | -$13 | -$7 |